Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily Q member 2 (KCNQ2) is a protein that forms part of voltage-gated potassium channels in the brain. These channels are essential for regulating the electrical activity of neurons by controlling the flow of potassium ions out of nerve cells. The functional channel is a tetramer composed of four alpha subunits, either all KCNQ2 or a combination with KCNQ3 subunits. KCNQ2 encodes an alpha subunit that contributes to forming potassium channels responsible for generating the M-current in neurons. The M-current is crucial because it prevents excessive neuronal firing by stabilizing membrane potential and limiting repetitive action potentials. Mutations in KCNQ2 are associated with several epilepsy syndromes, including Benign Familial Neonatal Seizures (BFNS) and Developmental and Epileptic Encephalopathies (DEE).
Modulation of potassium ion flow through voltage-gated channels, affecting neuronal excitability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel subfamily Q member 2 (KCNQ2).